Showing 1 - 3 results of 3 for search 'Xiaobo Cheng', query time: 0.02s Refine Results
  1. 1
    Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors

    Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors by Chenli Qiu, Chenli Qiu, Jing Wang, Lingyan Zhu, Xiaobo Cheng, Xiaobo Cheng, Bili Xia, Yanling Jin, Ran Qin, LinXia Zhang, Huiliang Hu, Jia Yan, Chen Zhao, Xiaoyan Zhang, Xiaoyan Zhang, Jianqing Xu, Jianqing Xu

    Published 2022-10-01
    Get full text
    Article
  2. 2
    A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19

    A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 by Weihui Fu, Yan Liu, Lu Xia, Min Li, Zhigang Song, Huiliang Hu, Zongguo Yang, Lin Wang, Xiaobo Cheng, Mei Wang, Rongrong Jiang, Li Liu, Xiaoting Mao, Jun Chen, Yun Ling, Lin Zhang, Jin Yan, Fei Shan, Corklin Steinhart, Xiaoyan Zhang, Tongyu Zhu, Jianqing Xu, Hongzhou Lu

    Published 2020-08-01
    Get full text
    Article
  3. 3
    An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19

    An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 by Weihui Fu, Yan Liu, Li Liu, Huiliang Hu, Xiaobo Cheng, Ping Liu, Zhigang Song, Lijun Zha, Shimeng Bai, Tingting Xu, Songhua Yuan, Fengru Lu, Zhiying Shang, Yihong Zhao, Jing Wang, Jun Zhao, Longfei Ding, Jun Chen, Lin Zhang, Tongyu Zhu, Xiaoyan Zhang, Hongzhou Lu, Jianqing Xu

    Published 2020-10-01
    Get full text
    Article

Search Tools: